D.A. Davidson & Co’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-23,550
| Closed | -$98K | – | 1034 |
|
|
2019
Q4 | $98K | Buy |
23,550
+2,790
| +13% | +$11.6K | ﹤0.01% | 983 |
|
|
2019
Q3 | $62K | Sell |
20,760
-2,800
| -12% | -$8.36K | ﹤0.01% | 981 |
|
|
2019
Q2 | $148K | Buy |
23,560
+2,025
| +9% | +$12.7K | ﹤0.01% | 928 |
|
|
2019
Q1 | $120K | Buy |
21,535
+8,455
| +65% | +$47.1K | ﹤0.01% | 1078 |
|
|
2018
Q4 | $87K | Buy |
+13,080
| New | +$87K | ﹤0.01% | 1060 |
|
|
2017
Q3 | – | Sell |
-4,600
| Closed | -$75K | – | 1603 |
|
|
2017
Q2 | $75K | Sell |
4,600
-800
| -15% | -$13K | ﹤0.01% | 1375 |
|
|
2017
Q1 | $77K | Sell |
5,400
-4,825
| -47% | -$68.8K | ﹤0.01% | 1348 |
|
|
2016
Q4 | $141K | Buy |
10,225
+7,025
| +220% | +$96.9K | ﹤0.01% | 1151 |
|
|
2016
Q3 | $57K | Buy |
3,200
+2,400
| +300% | +$42.8K | ﹤0.01% | 1464 |
|
|
2016
Q2 | $11K | Buy |
+800
| New | +$11K | ﹤0.01% | 1934 |
|